Last reviewed · How we verify
Kaposi's Sarcoma Skin Lesions
Approved treatments
- Retin-A · Bausch Health
Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation. - Panretin · Advanz
Panretin works by binding to retinoic acid receptors in the skin, which helps to slow down the growth of cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Kaposi's Sarcoma Skin Lesions patent landscape — cliff calendar, originator estates, attackable patents
- Kaposi's Sarcoma Skin Lesions treatment landscape brief
- Kaposi's Sarcoma Skin Lesions treatment updates RSS
Frequently asked questions about Kaposi's Sarcoma Skin Lesions
What drugs treat Kaposi's Sarcoma Skin Lesions?
Tracked treatments include Retin-A, Panretin.
What is the treatment for Kaposi's Sarcoma Skin Lesions?
Standard treatment for Kaposi's Sarcoma Skin Lesions includes Retin-A, Panretin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Kaposi's Sarcoma Skin Lesions patent cliff · Kaposi's Sarcoma Skin Lesions CI report
- Treatment: Retin-A · Bausch Health
- Treatment: Panretin · Advanz
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing